Literature DB >> 16600195

IL-21 dependent IgE production in human and mouse in vitro culture systems is cell density and cell division dependent and is augmented by IL-10.

Timothy H Caven1, Anne Shelburne, Jun Sato, Yee Chan-Li, Steve Becker, Daniel H Conrad.   

Abstract

IL-21 is known to enhance immunoglobulin production using human in vitro models. Using either PBMC or purified tonsilar B cells both stimulated with anti-CD40, IL-4+/-IL-21, this enhancement was shown to correlate with increased cell division especially for IgE and to a lesser extent for IgM and total IgG. Cell division was monitored by CFSE staining and maximum cell division was found at low initial cell plating densities. A correlation between increased cell division and IL-10-mediated enhancement of IgE production was also seen; however, increased cell division plays a smaller role with IL-10 than IL-21. This is further emphasized in that when IL-10 and IL-21 were added together there was a further synergistic increase in IgE seen, but no accompanying further increase in cell division. The mouse system was also examined for IL-21 effects as a function of cell concentration, and as in humans, IL-21 added to murine cells increased IgE production over IL-4/CD40 stimulated cells at lower cell concentrations; however, IL-21 significantly reduced IgE at higher plated cell concentrations.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16600195     DOI: 10.1016/j.cellimm.2006.03.001

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  16 in total

1.  Epoxyeicosatrienoic acids are involved in the C(70) fullerene derivative-induced control of allergic asthma.

Authors:  Sarah K Norton; Dayanjan S Wijesinghe; Anthony Dellinger; Jamie Sturgill; Zhiguo Zhou; Suzanne Barbour; Charles Chalfant; Daniel H Conrad; Christopher L Kepley
Journal:  J Allergy Clin Immunol       Date:  2012-06-02       Impact factor: 10.793

2.  Specialized proresolving mediators (SPMs) inhibit human B-cell IgE production.

Authors:  Nina Kim; Sesquile Ramon; Thomas H Thatcher; Collynn F Woeller; Patricia J Sime; Richard P Phipps
Journal:  Eur J Immunol       Date:  2015-11-02       Impact factor: 5.532

3.  BCR ligation antagonizes the IL-21 enhancement of anti-CD40/IL-4 plasma cell differentiation and IgE production found in low density human B cell cultures.

Authors:  Timothy H Caven; Jamie L Sturgill; Daniel H Conrad
Journal:  Cell Immunol       Date:  2007-09-21       Impact factor: 4.868

4.  A potential new target for asthma therapy: a disintegrin and metalloprotease 10 (ADAM10) involvement in murine experimental asthma.

Authors:  J A Mathews; J Ford; S Norton; D Kang; A Dellinger; D R Gibb; A Q Ford; H Massay; C L Kepley; P Scherle; A D Keegan; D H Conrad
Journal:  Allergy       Date:  2011-05-10       Impact factor: 13.146

5.  Glutamate signaling through the kainate receptor enhances human immunoglobulin production.

Authors:  Jamie L Sturgill; Joel Mathews; Peggy Scherle; Daniel H Conrad
Journal:  J Neuroimmunol       Date:  2011-01-06       Impact factor: 3.478

Review 6.  Interleukin-21 as a potential therapeutic target for systemic lupus erythematosus.

Authors:  Jing Li; Hai-Feng Pan; Han Cen; Jing Tian; Yan Ma; Jin-Hui Tao; Dong-Qing Ye
Journal:  Mol Biol Rep       Date:  2010-11-24       Impact factor: 2.316

7.  129/SvJ mice have mutated CD23 and hyper IgE.

Authors:  Jill W Ford; Jamie L Sturgill; Daniel H Conrad
Journal:  Cell Immunol       Date:  2008-10-01       Impact factor: 4.868

8.  Regulation of the IgE response.

Authors:  Daniel H Conrad; David R Gibb; Jamie Sturgill
Journal:  F1000 Biol Rep       Date:  2010-02-24

9.  Adrenergic regulation of IgE involves modulation of CD23 and ADAM10 expression on exosomes.

Authors:  Caroline J Padro; Todd M Shawler; Matthew G Gormley; Virginia M Sanders
Journal:  J Immunol       Date:  2013-10-18       Impact factor: 5.422

10.  CD23: an overlooked regulator of allergic disease.

Authors:  Daniel H Conrad; Jill W Ford; Jamie L Sturgill; David R Gibb
Journal:  Curr Allergy Asthma Rep       Date:  2007-09       Impact factor: 4.806

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.